243 related articles for article (PubMed ID: 9168925)
21. The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.
Volkmann S; Dannull J; Moelling K
Biochimie; 1993; 75(1-2):71-8. PubMed ID: 7684936
[TBL] [Abstract][Full Text] [Related]
22. Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system.
Lavigne C; Thierry AR
Biochem Biophys Res Commun; 1997 Aug; 237(3):566-71. PubMed ID: 9299405
[TBL] [Abstract][Full Text] [Related]
23. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2.
Boulme F; Perälä-Heape M; Sarih-Cottin L; Litvak S
Biochim Biophys Acta; 1997 Apr; 1351(3):249-55. PubMed ID: 9130587
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
Zelphati O; Zon G; Leserman L
Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anti-HIV activity of phosphorothioate antisense DNA containing C-5 polyamine substituted 2'-deoxyuridine and/or acridine residues.
Shinozuka K; Okamoto T; Matsukura M; Sawai H
Nucleic Acids Symp Ser; 1997; (37):215-6. PubMed ID: 9586076
[TBL] [Abstract][Full Text] [Related]
26. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phage phi 29 assembly by antisense oligonucleotides targeting viral pRNA essential for DNA packaging.
Zhang C; Garver K; Guo P
Virology; 1995 Aug; 211(2):568-76. PubMed ID: 7645260
[TBL] [Abstract][Full Text] [Related]
28. Antisense oligonucleotides inhibit in vitro cDNA synthesis by HIV-1 reverse transcriptase.
Boiziau C; Tarrago-Litvak L; Sinha ND; Moreau S; Litvak S; Toulmé JJ
Antisense Nucleic Acid Drug Dev; 1996; 6(2):103-9. PubMed ID: 8843324
[TBL] [Abstract][Full Text] [Related]
29. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
Anazodo MI; Wainberg MA; Friesen AD; Wright JA
J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
[TBL] [Abstract][Full Text] [Related]
30. Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNAse H cleavage of in vitro synthesized p120 mRNA.
Weidner DA; Busch H
Oncol Res; 1994; 6(6):237-42. PubMed ID: 7865899
[TBL] [Abstract][Full Text] [Related]
31. Antisense phosphorothioate oligonucleotides targeted to the human chemokine receptor CXCR4.
Kusunoki A; Miyano-Kurosaki N; Kimura T; Takai K; Yamamoto N; Gushima H; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1709-19. PubMed ID: 11200267
[TBL] [Abstract][Full Text] [Related]
32. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.
Faria M; Wood CD; White MR; Hélène C; Giovannangeli C
J Mol Biol; 2001 Feb; 306(1):15-24. PubMed ID: 11178890
[TBL] [Abstract][Full Text] [Related]
33. Sense antisense nonantisense. Can these novel antivirals knock HIV senseless?
Chang HE; Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Feb; 1(1):11-8. PubMed ID: 11362229
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs.
Kuwasaki T; Hatta M; Takeuchi H; Takaku H
J Antimicrob Chemother; 2003 Apr; 51(4):813-9. PubMed ID: 12654739
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
36. Single strand targeted triplex-formation. Destabilization of guanine quadruplex structures by foldback triplex-forming oligonucleotides.
Kandimalla ER; Agrawal S
Nucleic Acids Res; 1995 Mar; 23(6):1068-74. PubMed ID: 7537368
[TBL] [Abstract][Full Text] [Related]
37. Properties of quadruplex oligonucleotides with anti-HIV-1 activity.
Tamura Y; Yoshida M; Suzuki J; Hiratou T; Miyano-Kurosaki N; Takai K; Takaku H
Nucleic Acids Symp Ser; 2000; (44):181-2. PubMed ID: 12903328
[TBL] [Abstract][Full Text] [Related]
38. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
Lavigne C; Yelle J; Sauve G; Thierry AR
AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
[TBL] [Abstract][Full Text] [Related]
39. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
